Stargazer Pharmaceuticals Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
- Investors
-
1
Stargazer Pharmaceuticals General Information
Description
Developer of biopharmaceutical drugs intended to focus on rare diseases of the eye. The company is focused on the development of a novel treatment option for Stargardt Disease, an inherited retinal degenerative disease, for which no treatment is available, enabling healthcare professionals with new therapeutics for the treatment of rare diseases.
Contact Information
Website
www.stargazerpharmaceuticals.comCorporate Office
- 200 Clarendon Street
- Floor 45, Mailbox 30
- Boston, MA 02215
- United States
Corporate Office
- 200 Clarendon Street
- Floor 45, Mailbox 30
- Boston, MA 02215
- United States
Stargazer Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 30-Mar-2022 | Completed | Out of Business | |||
| 2. Early Stage VC (Series A) | 09-Nov-2020 | Completed | Clinical Trials - Phase 2 | |||
| 1. Seed Round | 16-Apr-2018 | Completed | Clinical Trials - Phase 2 |
Stargazer Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Jr Pref | ||||||||
| Series A-3 | ||||||||
| Series A-2 | 4,642,856 | $0.000010 | 6% | $1.4 | $1.4 | 1x | $1.4 | 9.29% |
| Series A-1 | 7,000,000 | $0.000010 | 6% | $1 | $1 | 1x | $1 | 14% |
Stargazer Pharmaceuticals Comparisons
Industry
Financing
Details
Stargazer Pharmaceuticals Competitors (1)
One of Stargazer Pharmaceuticals’s competitors is Clearside Biomedical, a Formerly VC-backed company based in Alpharetta, GA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Clearside Biomedical | Formerly VC-backed | Alpharetta, GA |
Stargazer Pharmaceuticals Patents
Stargazer Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022256301-A1 | Methods and compounds for treating subjects with stargardt disease | Inactive | 01-Jun-2021 | ||
| US-D608097-S1 | Brush applicator with cap | Inactive | 25-Nov-2004 |
Stargazer Pharmaceuticals Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Retinal Degeneration Fund | Not-For-Profit Venture Capital | Minority |
Stargazer Pharmaceuticals FAQs
-
When was Stargazer Pharmaceuticals founded?
Stargazer Pharmaceuticals was founded in 2018.
-
Where is Stargazer Pharmaceuticals headquartered?
Stargazer Pharmaceuticals is headquartered in Boston, MA.
-
What industry is Stargazer Pharmaceuticals in?
Stargazer Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Stargazer Pharmaceuticals a private or public company?
Stargazer Pharmaceuticals is a Private company.
-
What is Stargazer Pharmaceuticals’s current revenue?
The current revenue for Stargazer Pharmaceuticals is .
-
How much funding has Stargazer Pharmaceuticals raised over time?
Stargazer Pharmaceuticals has raised $57M.
-
Who are Stargazer Pharmaceuticals’s investors?
Retinal Degeneration Fund has invested in Stargazer Pharmaceuticals.
-
Who are Stargazer Pharmaceuticals’s competitors?
Clearside Biomedical is a competitor of Stargazer Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
